Growth Metrics

Ultragenyx Pharmaceutical (RARE) Cash from Investing Activities Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -114.28%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 826.39%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -674.01%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -166.24%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -122.45%
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn -140.83%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -140.83%
Dec 31, 2025 -170.48%
Sep 30, 2025 142.53%
Jun 30, 2025 17.34%
Mar 31, 2025 27.07%
Dec 31, 2024 195.78%
Sep 30, 2024 -528.50%
Jun 30, 2024 -39.08%
Mar 31, 2024 -15.16%
Dec 31, 2023 37.64%
Sep 30, 2023 139.72%
Jun 30, 2023 25.58%
Mar 31, 2023 397.91%
Dec 31, 2022 -348.49%
Sep 30, 2022 -297.11%
Jun 30, 2022 291.94%
Mar 31, 2022 79.52%
Dec 31, 2021 -29.46%
Sep 30, 2021 57.44%
Jun 30, 2021 52.12%
Mar 31, 2021 -91.77%
Dec 31, 2020 45.54%
Sep 30, 2020 -220.73%
Jun 30, 2020 -47.43%
Mar 31, 2020 6.00%
Dec 31, 2019 -8.56%
Sep 30, 2019 389.44%
Jun 30, 2019 -12.21%
Mar 31, 2019 -42.47%
Dec 31, 2018 28.18%
Sep 30, 2018 -45.60%
Jun 30, 2018 -147.04%
Mar 31, 2018 -568.81%
Dec 31, 2017 902.33%
Sep 30, 2017 -43.27%
Jun 30, 2017 -187.87%
Mar 31, 2017 -148.77%
Dec 31, 2016 78.69%
Sep 30, 2016 136.54%
Jun 30, 2016 121.61%
Mar 31, 2016 635.67%
Dec 31, 2015 -97.17%
Sep 30, 2015 -961.02%
Jun 30, 2015 -304.03%
Mar 31, 2015 93.78%
Dec 31, 2014 -253.16%
Sep 30, 2014 -1,621.09%
Jun 30, 2014 36.04%
Mar 31, 2014 -333.10%